COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,254 Articles (22,733 medRxiv, 8,521 bioRxiv)

Most recent first Previous |  Page 2715: Articles 27141-27150  | Next

Visualizing the invisible: The effect of asymptomatic transmission on the outbreak dynamics of COVID-19
Peirlinck, M., Linka, K., Sahli Costabal, F., Bendavid, E., Bhattacharya, J., Ioannidis, J., Kuhl, E.
10.1101/2020.05.23.20111419 — Posted: 2020-05-26
Predicting COVID-19 spread and public health needs to contain the pandemic in West-Africa
Taboe, B. H., Salako, V. K., Ngonghala, C. N., GLELE KAKAI, R.
10.1101/2020.05.23.20111294 — Posted: 2020-05-26
Association between Cardiovascular Burden and Requirement of Intensive Care among Patients with Mild COVID-19
Tai, S., Tang, J., Yu, B., Tang, L., Wang, Y., Zhang, H., Zhu, W., Xiao, K., Wen, C., Tan, C., Jiang, Z., Jiang, C., Zhu, L., Jiang, L., Liu, Q., Hu, X., Fang, Z., Li, X., Sun, J., Zhu, Z., Yang, H., Tu, T., Xiao, Y., Chen, M., He, Y., Chai, X., Xu, J., Zhou, S.
10.1101/2020.05.25.20111757 — Posted: 2020-05-26
Serum SARS-COV-2 Nucleocapsid Protein：A Sensitivity and Specificity Early Diagnostic Marker for SARS-COV-2 Infection
Li, T., Wang, L., Wang, H., Li, X., Zhang, S., Xu, Y., Wei, W.
10.1101/2020.05.24.20111849 — Posted: 2020-05-26
Patient trajectories and risk factors for severe outcomes among persons hospitalized for COVID-19 in the Maryland/DC region
Garibaldi, B. T., Fiksel, J., Muschelli, J., Robinson, M. L., Rouhizadeh, M., Nagy, P., Gray, J. H., Malapati, H., Ghobadi-Krueger, M., Niessen, T. M., Kim, B. S., Hill, P. M., Ahmed, M. S., Dobkin, E. D., Blanding, R., Abele, J., Woods, B., Harkness, K., Thiemann, D. R., Bowring, M. G., Shah, A. B., Wang, M. C., Bandeen-Roche, K., Rosen, A., Zeger, S. L., Gupta, A.
10.1101/2020.05.24.20111864 — Posted: 2020-05-26
COVID-19: Impact of Obesity and Diabetes in Disease Severity
Al-Sabah, S. K., Al-Haddad, M., Al Youha, S., Jamal, M. H., AlMazeedi, S.
10.1101/2020.05.24.20111724 — Posted: 2020-05-26
Pitting the Gumbel and logistic growth models against one another to model COVID-19 spread
Bekker, A., Yoo, K., Arashi, M.
10.1101/2020.05.24.20111633 — Posted: 2020-05-26
Evaluation of ELISA tests for the qualitative determination of IgG, IgM and IgA to SARS-CoV-2
Colavita, F., Brogi, A., Lapa, D., Bordi, L., Matusali, G., Meschi, S., Marsella, P., Tesi, G., Bandini, T., Di Caro, A., Capobianchi, M. R., Castilletti, C.
10.1101/2020.05.24.20111682 — Posted: 2020-05-26
SARS-CoV-2 IgG Antibody Responses in New York City
Reifer, J., Hayum, N., Heszkel, B., Klagsbald, I., Streva, V. A.
10.1101/2020.05.23.20111427 — Posted: 2020-05-26 Discussion: Onsite
Hasty Reduction of COVID-19 Lockdown Measures Leads to the Second Wave of Infection
Hazem, Y., Natarajan, S., Berikaa, E.
10.1101/2020.05.23.20111526 — Posted: 2020-05-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).